316.58
Krystal Biotech Inc Azioni (KRYS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
2.46%
119.22
|
116.36 | 107.11 | 97.80 | 96.04 |
|
|
2.97%
60.80
|
62.67 | 62.84 | 56.43 | 56.73 |
| Operating Income/Loss |
8.81%
58.42
|
53.69 | 44.27 | 41.37 | 39.31 |
| Income/Loss From Continuing Operations Before Tax |
7.55%
66.08
|
61.44 | 51.13 | 47.97 | 46.77 |
| Income Tax Expense/Benefit |
105.28%
11.31
|
5.51 | -0.269 | -31.40 | 8.442 |
| Net Income/Loss |
2.08%
54.77
|
55.93 | 51.40 | 79.36 | 38.33 |
| Basic Average Shares |
0.82%
29.53
|
29.29 | 0.051 | 28.95 | 28.91 |
| Diluted Average Shares |
0.49%
30.66
|
30.51 | 0.122 | 29.83 | 29.75 |
| Basic Earnings Per Share |
3.14%
1.85
|
1.91 | 1.77 | 2.74 | 1.33 |
| Diluted Earnings Per Share |
2.19%
1.79
|
1.83 | 1.70 | 2.66 | 1.29 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):